We contribute to promoting human health by expanding frontiers, accelerating research, and reducing the risks of drug discovery.
Who We Are
Researchers at the Graduate School of Medicine, The University of Tokyo, have developed new technologies to measure GPCR activities with extraordinary sensitivity and specificity. They co-founded Tanso Biosciences in to apply their innovation and revolutionize GPCR drug discovery.
With its assay platform, <dfn>Tanso Biosciences</dfn> promotes human health by expanding frontiers, accelerating research, and reducing drug development risks. Tanso Biosciences is an academic spin-off and occupies university incubator spaces at the main campus in the central district of Tokyo. One of the co-founders, Hideaki Ogasawara, MD, PhD, MBA serves as Chief Executive Officer.
We coined the name Tanso by combining the kanji characters 探 (tan, exploration) and 創 (soh, creation) to indicate our aspirations of innovating a drug discovery platform and developing new drugs on it.
Send us a message via the form below or write to us at [email protected].
Service flow chart
Request a quotation
We hear about the study outline and propose experiments. A non-disclosure agreement is optional.
Place an order
You also ship your compounds to our lab and pay the fee via bank transfer.
Wait for a while
The turnaround time may be as short as two weeks but depends on the study scale and design and the backlog of orders.
Receive the report
We provide the study report via email.